US Stock Market Move | Diabetes treatment technology achieves major breakthroughs. Sana Biotechnology (SANA.US) surged more than 232%.
On Wednesday, Sana Biotechnology (SANA.US) surged over 232%, reaching $5.52.
On Wednesday, Sana Biotechnology (SANA.US) surged over 232%, reaching $5.52. In terms of news, Sana Biotechnology released positive data on its investigational treatment for Type 1 diabetes. The company stated that it transplanted its therapy, UP421, which utilizes a low-immunogenicity biological material core therapy, to a Type 1 diabetes patient who was not using any immunosuppressive drugs. The study did not find any safety issues, and the low-immunogenicity modified core therapy evaded immune reactions.
Related Articles
US Stock Market Move | Royal Caribbean Cruises (RCL.US) Falls 3% on Plan to Acquire Half of Sandals for $3 Billion
Meta (META.US) Wins More Wall Street Bullish Calls After Muse Goes Viral! Cantor Fitzgerald Raises Price Target to $860, Trillion-Dollar AI Agent Market in Sight
CENTRALCHINA MT (09982) plans to acquire a 25% stake in Lianheng Technology for HK$100 million, launching a "construction management + AI technology" business model.
US Stock Market Move | Royal Caribbean Cruises (RCL.US) Falls 3% on Plan to Acquire Half of Sandals for $3 Billion
Meta (META.US) Wins More Wall Street Bullish Calls After Muse Goes Viral! Cantor Fitzgerald Raises Price Target to $860, Trillion-Dollar AI Agent Market in Sight
CENTRALCHINA MT (09982) plans to acquire a 25% stake in Lianheng Technology for HK$100 million, launching a "construction management + AI technology" business model.
